RecruitingNAINTERVENTIONAL

Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder

This study is looking into a new, shorter therapy called SINTYA, designed specifically for young adults aged 16 to 25 who have Borderline Personality Disorder (BPD). BPD is a serious condition that can lead to impulsive and sometimes dangerous behaviours. Traditional long-term therapies haven't always worked well for this age group, possibly because of how BPD affects their brains, especially after difficult experiences. Researchers believe SINTYA, which involves one group and one individual session each week for 10 weeks, could help reduce impulsivity, self-harm, suicidal thoughts, and other BPD symptoms. The goal is to improve how young people with BPD feel and function in their daily lives after receiving this new therapy.

At a glance

Status

Recruiting

Phase

Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrolment target

Start

08 Nov 2023

Estimated completion

01 Sep 2026

Borderline Personality Disorder

What is this study about?

This study is about understanding if a new, shorter therapy called SINTYA can help young adults with Borderline Personality Disorder (BPD). BPD is a complex mental health condition that often begins in teenage years or early adulthood. It can lead to intense emotions, problems with relationships, impulsive actions, and sometimes self-harm or suicidal thoughts. These challenges can make daily life very difficult for those affected.

Often, therapies for BPD can be quite long. However, for young people aged 16 to 25, these longer approaches haven't always been as effective. This might be because the condition can affect their brains differently during these formative years, especially if they've experienced difficult events in the past. Researchers are hopeful that SINTYA, which is shorter and specifically designed for this age group, will be a better fit.

The SINTYA therapy involves attending one group session and one individual session each week for 10 weeks. The main aim is to see if this concentrated therapy can reduce common BPD symptoms like impulsivity, anger, feelings of hopelessness, and difficulties with managing emotions. The researchers also want to see if it can reduce self-destructive behaviours and improve overall well-being and ability to function in daily life, potentially leading to fewer hospital visits for mental health reasons.

Key takeaways

This study tests a new, short therapy (SINTYA) for young adults with BPD.
It aims to reduce impulsivity, self-harm, and emotional difficulties.
Participation involves 10 weeks of weekly group and individual therapy.
The study is for young adults aged 16-25 who speak and read French.
It offers a new approach for those who haven't benefited from traditional therapies.

Who may be eligible?

To join this study, participants need to be young adults between 16 and 25 years old and have a confirmed diagnosis of Borderline Personality Disorder (BPD) that is considered quite severe. You'll also need to be able to understand, read, and write in French, as the study materials and sessions will be in French. It's important that you fully understand what the study involves and are willing to take part in the assessments.

There are also some reasons why you wouldn't be able to join. For example, if you have a brain condition that could affect your thinking skills, or if your IQ is below 70. You also can't have a history of certain other mental health conditions like schizophrenia. If you've recently had or are currently having another specific type of BPD therapy, or if you're taking part in certain other clinical studies, you wouldn't be able to join this one. Finally, if for legal reasons you are not free to make your own decisions, you cannot participate.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you between 16 and 25 years old?
Do you have a diagnosis of Borderline Personality Disorder (BPD)?
Can you understand, read, and write in French?
Do you not have a brain condition that affects thinking?
Are you currently not in another specific BPD therapy or certain other clinical studies?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you would receive the SINTYA therapy program. This involves attending therapy sessions for a total of 10 weeks. There would be two sessions per week: one group therapy session and one individual therapy session. Throughout the study, you would have several assessments to check your symptoms and how you're feeling. These assessments help the researchers understand if the therapy is making a difference. The study does not involve new medications, only a specific type of therapy. The total duration of your active involvement would be the 10 weeks of therapy, plus any initial checks and final assessments.

Potential risks and benefits

Participating in this study could offer several potential benefits. You would receive a new, targeted therapy designed specifically for young adults with BPD, which may help reduce difficulties like impulsivity, self-harm, and intense emotions, potentially improving your daily life. However, as with any therapy, there's always a possibility that it might not be effective for everyone, or that discussing difficult feelings could be challenging at times. The researchers will have measures in place to support your well-being. Remember, you can choose to withdraw from the study at any point, for any reason, without it affecting your usual medical care.

Locations (1)

CHU de Nîmes
Verified postcode
Nîmes, France· Recruiting

Common questions

What is Borderline Personality Disorder (BPD)?

BPD is a mental health condition that affects how you think and feel about yourself and others, leading to problems with intense emotions, relationships, and impulsive behaviours.

How long does the SINTYA therapy last?

The SINTYA therapy program itself lasts for 10 weeks, with two sessions per week (one group and one individual).

Will I have to take any medication?

No, this study is focused on a new therapy approach, not on testing new medications. It does not involve taking any specific study-related drugs.

What if I don't speak French?

Unfortunately, participants need to be able to understand, read, and write French, as all the study materials and therapy sessions will be conducted in French.

Can I leave the study if I change my mind?

Yes, absolutely. You can choose to leave the study at any time, for any reason, and it will not affect the medical care you usually receive.

How to find out more

Clémentine Estric

clementine.estric@chu-nimes.fr 04 66 68 34 26 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.